China Jiuhao Health Industry Corporation Limited provided unaudited earnings guidance for the six months ended June 30, 2014. For the six months, the company expected to record a net profit of approximately HKD 90 million as compared with the unaudited loss of HKD 124 million for the six months ended June 30, 2013. The board considers that the significant improvement in the overall results of the Group for the six months ended June 30, 2014 as compared with the six months ended June 30, 2013 was principally due to the following reasons like there was a significant decrease in finance costs arising from the convertible note and promissory note of the Group over the six months ended June 30, 2014 as compared to the six months ended June 30, 2013; there was a significant increase in other income and other gains, mainly arising from the fair value gain on investment securities over the six months ended June 30, 2014 as compared to the six months ended June 30, 2013; there was a gain on disposal of discontinued operations of approximately HKD 11 million over the six months ended June 30, 2014 as compared to a loss from discontinued operations of approximately HKD 69 million for the six months ended June 30, 2013; and Health industry segment results improved during the period due to the tight control over costs and expenses which offset the impact of decline in sales revenue during the period attributed to the continuous contraction in the high-end consumption market in China.